RxDoctor Payments Data

Dawson Lim

Monongahela, PANPI 1356304513

Payments from drug & device makers

$3,784in general payments, 2019–2025

Across 229 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$338
  • Amgen$291
  • AstraZeneca$260
  • Seagen Inc.$245
  • Pfizer$245
  • Novartis$222
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$3,46191%
  • Education$3229%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →